Deakin University
Browse

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

conference contribution
posted on 2015-05-20, 00:00 authored by Mustafa Khasraw, Violet Rudo Mukaro, Linda West, Conrad Brandt, Anne Maree Woollett, Michelle Edwards, Robert Spokes, Gregory Mitchell, Kimberley Prince, Theresa M Hayes, Ian CollinsIan Collins, Alexander David Guminski, Sally E Baron-Hay, Inger Helen Olesen, Jacinta Bryan, Susan Bowles, Shu Fen Wong, David M Ashley, Sujata Patil
Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).

History

Volume

33

Pagination

e12025-e12025

Location

Chicago, Ill.

Start date

2015-05-29

End date

2015-06-02

ISSN

0732-183X

eISSN

1527-7755

Language

eng

Publication classification

E3.1 Extract of paper

Title of proceedings

ASCO 2015 : Illumination adn innovation transforming data into learning : Proceedings of American Society of Clinical Oncology 2015 conference

Event

American Society of Clinical Oncology. Conference (2015 : Chicago, Ill.)

Issue

15_suppl

Publisher

American Society of Clinical Oncology

Place of publication

Alexandria, Va.

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC